Methods of use of trk receptor modulators

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/12 (2006.01) A61K 31/138 (2006.01)

Patent

CA 2671613

The present invention relates to methods of treating or preventing retinal ganglion cell (RGC) death and/or glaucoma using modulators of neurotrophic receptors that comprise .beta.-turn peptidomimetic cyclic compounds or derivatives thereof. The neurotrophic receptor modulators can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat or prevent ocular hypertension, RGC death and/or glaucoma.

L'invention concerne des procédés de traitement ou de prévention de la mort de la cellule ganglionnaire rétinienne (RGC) et/ou du glaucome, en utilisant des modulateurs de récepteurs neurotrophiques, qui comprennent des composés cycliques peptidomimétiques à coude .beta. ou des dérivés de ceux-ci. Les modulateurs de récepteur neurotrophique peuvent être utilisés seuls, en combinaison avec et/ou en même temps qu'un ou plusieurs autres composés, molécules ou médicaments qui traitent ou préviennent l'hypertension oculaire, la mort de la RGC et/ou le glaucome.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods of use of trk receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of use of trk receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of use of trk receptor modulators will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1642721

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.